Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma

NCT00004162 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: sargramostim
DRUG: methotrexate
DRUG: pegylated liposomal doxorubicin hydrochloride
DRUG: vincristine sulfate

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]